Antibody-based immunosuppression following liver transplantation: the plot thickens.
The role of antibody-based immunosuppression in liver transplant recipients remains an area in which prospective trials are needed.
Heimbach
J K
JK
Charlton
M R
MR
D000906:Antibodies / Q000737:chemistry* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000009:adverse effects*; D015999:Multivariate Analysis; D015995:Prevalence; D013601:T-Lymphocytes / Q000378:metabolism; D016896:Treatment Outcome
D000906:Antibodies; D007166:Immunosuppressive Agents